Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension

Hypertension

Volumn 34, Issue 6, 1999, Pages 1186-1192

  Lin, Ruby C Y ^a   Wang, William Y S ^a   Morris, Brian J ^a  

^a NONE

Author keywords

Cross sectional studies; Genes; Glucocorticoids; Hypertension, essential; Microsatellites; Whites

Indexed keywords

GLUCOCORTICOID RECEPTOR; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CAUCASIAN; ESSENTIAL HYPERTENSION; FEMALE; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SIBLING;

EID: 0033456160     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.6.1186     Document Type: Article

References (50)

1. Walker BR, Best R, Shackleton CHL, Padfield LP, Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension. 1996;27:190-196.
2. Whitworth JA, Brown MA, Kelly JJ, Williamson PM. Mechanisms of cortisol-induced hypertension in humans. Steroids. 1995;60:76-80.
3. Provencher PH, Saltis J, Funder JW. Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J Steroid Biochem Mol Biol. 1995;52: 219-225.
4. Li M, Wen C, Fraser T, Whitworth JA. Adrenocorticotropin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism. J Hypertens. 1999;17:1-8.
5. Gardner DS, Jackson AA, Langley-Evans SC. The effect of prenatal diet and glucocorticoids on growth and systolic blood pressure in the rat. Proc Nutr Soc. 1998;57:235-240.
6. Mulatero P, Panarelli M, Schiavone D, Rossi A, Mengozzi G, Kenyon CJ, Chiandussi L, Veglio F. Impaired cortisol binding to glucocorticoid receptors in hypertensive patients. Hypertension. 1997;30:1274-1278.
7. Encio IJ, Detera-Wadleight SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem. 1991;266:7182-7188.
8. Thériault A, Boyd E, Harrap SB, Hollenberg SM, Connor JM. Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum Genet. 1989;83:289-291.
9. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991; 87:680-686.
10. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest. 1993;91:1918-1925.
11. Karl M, Lamberts SW, Detera-Wadleigh SD, Encio LJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab. 1993;76:683-689.
12. Koper JW, Stolk RP, de Lange P, Huizengo NATM, Molijn G-J, Pols HAP, Grobbee DE, Karl M, de Jong FH, Brinkmann AO, Lamberts SWJ. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997;99: 663-668.
13. Bamberger CM, Bamberger AM, De Castro M, Chrousos GP. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest. 1995;95:2435-2441.
14. Dahia PLM, Honegger J, Reincke M, Jacobs RA, Mirtella A, Fahlbusch R, Besser GM, Chew SL, Grossman AB. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin Endocrinol Metab. 1997;82:1088-1093.
15. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and renin-angiotensin system: a four comers approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473-482.
16. Litchfield WR, Hunt SC, Jeunemaitre X, Fisher NDL, Hopkins PN, Williams RR, Corvol P, Williams GH. Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. Hypertension 1998;31:569-574.
17. Kenyon CJ, Panarelli M, Holloway CD, Dunlop D, Morton JJ, Connell JMC, Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J Steroid Biochem Mol Biol. 1993; 45:7-11.
18. Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, Kenyon CJ. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab. 1998;83:1846-1852.
19. Palmer LA, Hukku B, Harmon JM. Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens. Cancer Res. 1992;52:6612-6618.
20. Buemann B, Vohl M-C, Chagnon M, Chagnon YC, Gagnon J, Pérusse L, Dionne F, Després J-P, Tremblay A, Nadeau A, Bouchard C. Abdominal visceral fat is associated with a Bcl I restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 1997;5: 186-192.
21. Walker BR, Phillips DI, Noon JP, Panarelli M, Andrew R, Edwards HV, Holton DW, Seckl JR, Webb DJ, Watt GC. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension. 1998;31: 891-895.
22. Galtan D, DeBold CR, Turney MK, Zhuo P, Orth DN, Kovacs WJ. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol. 1995;9:1193-1201.
23. Huizenga NATM, Koper JW, deLange P, Pols HAP, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, de Jong FH, Lamberts SWJ. A polymorphism in the glucocorticoid receptor gene may be associated with increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144-151.
24. Weaver JU, Hitman GA, Kopelman PG. An association between a BclI restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol. 1992; 9:295-300.
25. Li X, Wise CA, Le Paslier D, Hawkins AL, Griffin CA, Pittler SJ, Lovett M, Jabs EW. A YAC contig of approximately 3 Mb from human chromosome 5q31→q33. Genomics. 1994;19:470-477.
26. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nat Genet. 1996;12:122-122.
27. Morris BJ, Jeyasingam CL, Zhang W, Curtain RP, Griffiths LR. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. Hypertension. 1997;30:1640-1641.
28. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension. 1998;32:1094-1097.
29. Glenn CL, Wang WYS, Morris BJ. Gene for essential hypertension discovered from genome scanning. Abstract presented at: HUGO Human Genome Meeting; March 27-30, 1999; Brisbane, Australia.
30. Cox NJ, Bell GI. Disease associations: chance, artifact, or susceptibility genes. Diabetes. 1989;38:947-950.
31. 235→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993;197:833-839.
32. Hodge SE. The information contained in multiple sibling pairs. Genet Epidemiol. 1984;1:109-122.
33. Jabs EW, Li X, Lovett M, Yamaoka LH, Taylor E, Speer MC, Coss C, Cadle R, Hall B, Brown K, Kidd KK, Dolganov G, Polymeropoulos MH, Meyers DA. Genetic and physical mapping of the Treacher Collins syndrome locus with respect to loci on the chromosome 5q3 region. Genomics. 1993;18:7-13.
34. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995;59:97-105.
35. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet. 1988;42:113-124.
36. Davis S, Weeks DE. Comparison of nonparametric statistics for detection of linkage in nuclear families: single-marker evaluation. Am J Hum Genet. 1997;61:1431-1444.
37. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly-linked markers. Am J Hum Genet. 1995;57:1221-1232.
38. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995;57:439-454.
39. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11: 241-247.
40. Weber JL, Polymeropoulos MH, May PE, Kwitek AE, Xiao H, McPherson JD, Wasmuth JJ. Mapping of human chromosome 5 microsatellite DNA polymorphisms. Genomics. 1991;11:695-700.
41. Schlessman JJ. Case-Control Studies: Design, Conduct, Analysis. Oxford, UK: Oxford University Press; 1982.
42. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
43. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Schumacher MC, Lifton RP, Lalouel JM. Are there interactions and relations between environmental factors predisposing to high blood pressure. Hypertension. 1991;18(suppl. I):I-29-I-37.
44. Weeks DE, Lathrop M. Polygenic disease: methods for mapping complex disease traits. Trends Genet. 1995;11:513-519.
45. Rutherford S, Morris BJ, Griffiths LR. In search of hypertension gene loci: a genome-wide scan using affected siblings. Abstract presented at the Annual Scientific Meeting of the Human Genetics Society of Australia; July 1997; Perth, Australia.
46. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
47. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med. 1993;119:1113-1124.
48. Horowitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung TL. Nuclear coactivators and corepressors. Mol Endocrinol. 1996;10: 1167-1177.
49. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet. 1998;7:1379-1383.
50. 2-adrenergic receptor genes with blood pressure and body mass index. Am J Physiol. 1999;276:H1379-H1384.